Clinical trial
Topotecan in Treating Children With Refractory Leukemia
NCT00002705 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002705 |
|---|---|
| Title | Topotecan in Treating Children With Refractory Leukemia |
| Official title | TOPOTECAN FOR CHILDREN WITH REFRACTORY LEUKEMIA, A PEDIATRIC ONCOLOGY GROUP PHASE I COOPERATIVE AGREEMENT STUDY |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride |
| Enrollment | 3 |
| Start date | Apr 1, 1996 |
| Primary completion | Jan 1, 2001 |
| First posted | Jul 1, 2004 |
| Last update posted | Feb 1, 2013 |
| Countries | Canada, Puerto Rico, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: